Skip to content

EV / EBITDA at other companies

Stryker logo
StrykerSYK
22.1×-11.8×
Cardinal Health logo
Cardinal HealthCAH
16.9×+4.4×
Boston Scientific logo
Boston ScientificBSX
28.3×-8.5×
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
10.3×
Medtronic logo
MedtronicMDT
13.9×-1.5×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
3.1×+0.5×

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Calculated from Avanos Medical’s reported figures.

Based on the most recent quarter.

The official record: Avanos Medical’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's EV / EBITDA?
Avanos Medical (AVNS) reported EV / EBITDA of 15.3× in Q3 2024.
How has Avanos Medical's EV / EBITDA changed year-over-year?
Avanos Medical's EV / EBITDA decreased by 23.0% year-over-year, from 19.9× to 15.3×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.